Search Videos and More

Showing 1 - 12 of 139 results

Previous| 1 | 2 | 3 ...12 |Next


Course

Atlantic Regional Hematopathology Meeting

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this in-person education program is designed to focus on the role of molecular pathology and new technologies in diagnosis, prognostic stratification, and treatment of complex cases. Participants will gain insights into the significant changes, updates, and new categories in the 5th Edition of the World Health Organization Classification of Hematolympoid Tumors. Renowned invited pathologists and senior authors of the new WHO edition-Dr. Joseph Khoury, Dr. German Ott, and Dr. Sanam Loghavi-will discuss notable updates, modications, and new classifications in the morphology and molecular genetics of hematologic neoplasms that can be immediately applied in practice. As usual, there will be case-based podium presentations followed by discussion. A poster session will also take place.
Putting the Nurse Back into Nurse Navigation News

Putting the Nurse Back into Nurse Navigation

More than 15 years ago, Fox Chase Cancer Center launched a Nurse Navigation system to expedite the journey through complex cancer care with experienced oncologic nurses as a patient’s first 'point-of-contact' via phone.
HER2-Targeted Agents: Not Just for Breast Cancer News

HER2-Targeted Agents: Not Just for Breast Cancer

With 20% of breast cancers driven by alterations to the HER2 gene, inhibiting the expression of this gene has been an objective of researchers and clinicians for decades, and a number of inhibitory therapies have been developed.
Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center News

Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center

Over the past year, the Fox Chase Cancer Center Radiation Oncology team led by Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase and the Lewis Katz School of Medicine at Temple University, has boldly moved adaptive radiation therapy into the mainstream, demonstrating its clinical advantages for treating prostate, bladder, liver, pancreas, breast, lung, and head and neck cancers.
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community News

Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community

Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be more effective alternative treatments.
Fox Chase Fellows – Winter 2024 News

Fox Chase Fellows – Winter 2024

People say you never really leave Fox Chase. Just ask Matt Zibelman, MD, who was a Fox Chase hematology/oncology fellow and now is the GU Service Line Director of Clinical and Translational Research—or his colleague Mark Hallman, MD, PhD, a former Fox Chase Radiation Oncology resident, now serving as the GU Service Line Clinical Director
Many Legacies to Carry On News

Many Legacies to Carry On

In May 2023, Michael O. Meyers, MD, a surgical oncologist at UNC, was named the James F. and Alice B. Newsome Distinguished Professor.
Fox Chase Researcher’s Presentation Highlights Unique Approach to Esophagectomy at American College of Surgeons Clinical Congress News

Fox Chase Researcher’s Presentation Highlights Unique Approach to Esophagectomy at American College of Surgeons Clinical Congress

Nosayaba Enofe, MD, presented his experience with a unique minimally invasive hybrid approach to esophagectomy at the American College of Surgeons Clinical Congress.
Symposium

22nd Annual Highlights of the 2023 San Antonio Breast Cancer Symposium

New Directions in the Diagnosis and Treatment of Hematologic Cancers Course

New Directions in the Diagnosis and Treatment of Hematologic Cancers

DATE: Tuesday, April 16, 2024
Inspiring Residents to Climb Higher News

Inspiring Residents to Climb Higher

When asked why he chose Fox Chase Cancer Center for his urologic surgery fellowship (2019-2021), Marshall Strother, MD, responds, “I liked the way ‘Fox,’ as he calls Fox Chase, has an exacting, intentional, and deliberate method of training. Hierarchies are flattened there, allowing new surgeons to work and learn with the most experienced on the team.”
Recognizing International Excellence News

Recognizing International Excellence

Fox Chase Cancer Center is known around the world as an international leader in bold urologic cancer care, scientific research, translational research, and education. These are the people whose accomplishments make it happen.

Showing 1 - 12 of 139 results

Previous| 1 | 2 | 3 ...12 |Next